Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma

被引:2
作者
Ludvigsen, Maja [1 ,2 ]
Campbell, Amanda Jessica [2 ]
Enemark, Marie Beck [1 ,2 ]
Hybel, Trine Engelbrecht [1 ,2 ]
Karjalainen-Lindsberg, Marja-Liisa [3 ]
Beiske, Klaus [4 ]
Bjerre, Mette [5 ]
Pedersen, Lars Moller [6 ]
Holte, Harald [7 ,8 ,9 ]
Leppa, Sirpa [10 ,11 ,12 ]
Jorgensen, Judit Meszaros [1 ]
Honore, Bent [13 ]
机构
[1] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark
[2] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[3] Helsinki Univ Hosp, Dept Pathol, Helsinki, Finland
[4] Oslo Univ Hosp, Dept Pathol, Div Canc Med, Oslo, Norway
[5] Aarhus Univ, Dept Clin Med, Med Steno Aarhus Res Lab, Aarhus, Denmark
[6] Zealand Univ Hosp, Roskilde, Denmark
[7] Oslo Univ Hosp, Dept Oncol, Oslo, Norway
[8] Univ Oslo, Inst Clin Med, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway
[9] Norwegian Canc Genom Consortium, Oslo, Norway
[10] Univ Helsinki, Fac Med, Res Program Unit, Appl Tumor Genom, Helsinki, Finland
[11] Helsinki Univ Hosp, Comprehens Canc Ctr, Dept Oncol, Helsinki, Finland
[12] iCAN Digital Precis Canc Med Flagship, Helsinki, Finland
[13] Aarhus Univ, Dept Biomed, Aarhus, Denmark
关键词
GENE-EXPRESSION;
D O I
10.1038/s41408-023-00931-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 15 条
  • [1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    Alizadeh, AA
    Eisen, MB
    Davis, RE
    Ma, C
    Lossos, IS
    Rosenwald, A
    Boldrick, JG
    Sabet, H
    Tran, T
    Yu, X
    Powell, JI
    Yang, LM
    Marti, GE
    Moore, T
    Hudson, J
    Lu, LS
    Lewis, DB
    Tibshirani, R
    Sherlock, G
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Armitage, JO
    Warnke, R
    Levy, R
    Wilson, W
    Grever, MR
    Byrd, JC
    Botstein, D
    Brown, PO
    Staudt, LM
    [J]. NATURE, 2000, 403 (6769) : 503 - 511
  • [2] Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
    Barrans, Sharon
    Crouch, Simon
    Smith, Alex
    Turner, Kathryn
    Owen, Roger
    Patmore, Russell
    Roman, Eve
    Jack, Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) : 3360 - 3365
  • [3] Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion
    Chan, AY
    Coniglio, SJ
    Chuang, YY
    Michaelson, D
    Knaus, UG
    Philips, MR
    Symons, M
    [J]. ONCOGENE, 2005, 24 (53) : 7821 - 7829
  • [4] Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
    Crump, Michael
    Neelapu, Sattva S.
    Farooq, Umar
    Van den Neste, Eric
    Kuruvilla, John
    Westin, Jason
    Link, Brian K.
    Hay, Annette
    Cerhan, James R.
    Zhu, Liting
    Boussetta, Sami
    Feng, Lei
    Maurer, Matthew J.
    Navale, Lynn
    Wiezorek, Jeff
    Go, William Y.
    Gisselbrecht, Christian
    [J]. BLOOD, 2017, 130 (16) : 1800 - 1808
  • [5] Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
    De Buck, Mieke
    Gouwy, Mieke
    Wang, Ji Ming
    Van Snick, Jacques
    Opdenakker, Ghislain
    Struyf, Sofie
    Van Damme, Jo
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (17) : 1725 - 1755
  • [6] Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents
    Deng, Manman
    Xu-Monette, Zijun Y.
    Pham, Lan, V
    Wang, Xudong
    Tzankov, Alexandar
    Fang, Xiaosheng
    Zhu, Feng
    Visco, Carlo
    Bhagat, Govind
    Dybkaer, Karen
    Chiu, April
    Tam, Wayne
    Zu, Youli
    Hsi, Eric D.
    You, Hua
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Moller, Michael B.
    Parsons, Benjamin M.
    Hagemeister, Fredrick
    van Krieken, J. Han
    Piris, Miguel A.
    Winter, Jane N.
    Li, Yong
    Xu, Bing
    Liu, Phillip
    Young, Ken H.
    [J]. MOLECULAR CANCER RESEARCH, 2021, 19 (02) : 249 - 260
  • [7] Expression of ribosomal and actin network proteins and immunochemotherapy resistance in diffuse large B cell lymphoma patients
    Ednersson, Susanne Bram
    Stenson, Martin
    Stern, Mimmie
    Enblad, Gunilla
    Fagman, Henrik
    Nilsson-Ehle, Herman
    Hasselblom, Sverker
    Andersson, Per-Ola
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (06) : 770 - 781
  • [8] Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma
    Fornecker, Luc-Matthieu
    Muller, Leslie
    Bertrand, Frederic
    Paul, Nicodeme
    Pichot, Angelique
    Herbrecht, Raoul
    Chenard, Marie-Pierre
    Mauvieux, Laurent
    Vallat, Laurent
    Bahram, Seiamak
    Cianferani, Sarah
    Carapito, Raphael
    Carapito, Christine
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study
    Holte, H.
    Leppa, S.
    Bjorkholm, M.
    Fluge, O.
    Jyrkkio, S.
    Delabie, J.
    Sundstrom, C.
    Karjalainen-Lindsberg, M. -L.
    Erlanson, M.
    Kolstad, A.
    Fossa, A.
    Ostenstad, B.
    Lofvenberg, E.
    Nordstrom, M.
    Janes, R.
    Pedersen, L. M.
    Anderson, H.
    Jerkeman, M.
    Eriksson, M.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (05) : 1385 - 1392
  • [10] Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
    Leppa, Sirpa
    Jorgensen, Judit
    Tierens, Anne
    Meriranta, Leo
    Ostlie, Ingunn
    Brown, Peter de Nully
    Fagerli, Unn-Merete
    Larsen, Thomas Stauffer
    Mannisto, Susanna
    Munksgaard, Lars
    Maisenholder, Martin
    Vasala, Kaija
    Meyer, Peter
    Jerkeman, Mats
    Bjorkholm, Magnus
    Fluge, Oystein
    Jyrkklo, Sirkku
    Liestol, Knut
    Ralfkiaer, Elisabeth
    Spetalen, Signe
    Beiske, Klaus
    Karjalainen-Lindsberg, Marja-Liisa
    Holte, Harald
    [J]. BLOOD ADVANCES, 2020, 4 (09) : 1906 - 1915